Bioinformatics Services Market Size, Share & Trends Analysis Report By Product (Sequencing Services, Data Analysis, Drug Discovery Services, Differential, Others), By Applications (Transcriptomics, Epigenetics, Whole-Genome, Whole Exome, Proteomics, Others), By End Use, By Region, and Segment Forecasts - 2035

BIOINFORMATICS SERVICES MARKET OVERVIEW

The bioinformatics services market size is expected to grow from USD 1779.76 million in 2025 to USD 1959.52 million in 2026 and is forecast to reach USD 5285.15 million by 2035 at 10.1% CAGR over 2026-2035.

Bioinformatics services are those that gather, store, process, and interpret biological data using computer technology. The product has been growing because of increased demand. The product is very beneficial. By using these services, we can better comprehend health and illness. Bioinformatics is the use of computational and analytical techniques for biological data collection and interpretation. It is an interdisciplinary field that draws on biology, physics, mathematics, and computer science.

The demand for bioinformatics services is being driven by increasing innovation in the biopharmaceutical, biotechnology, and medication disclosure sectors. As a result, industry players are outsourcing bioinformatic services to analyze and interpret clinical data generated during the drug discovery process, which has led to the emergence of service providers. The product is very useful. The demand for this product is increasing. The market is growing because of increased demand for this product. The growing demand for these services across a variety of industries, including genomic research, forensics, and biopharmaceuticals, among others, is expected to propel the growth of the global bioinformatics services market over the forecast period. The growing use of cloud-based bioinformatics solutions has resulted in lower costs and greater accessibility to clinical data. This factor has augmented the Bioinformatics Services Market growth.

The United States remains the leading market for bioinformatics services, supported by more than 3,000 biotechnology companies, over 1,500 clinical laboratories, and widespread adoption of next-generation sequencing and AI-driven genomic analysis. The country hosts major genome research initiatives and accounts for the largest share of North American bioinformatics demand. More than 2 million human genomes have been sequenced across U.S.-based research and healthcare programs, accelerating precision medicine and drug discovery. Strong collaboration among pharmaceutical firms, academic institutions, and cloud computing providers continues to expand demand for data analysis, multiomics, and computational biology services across clinical and research applications.

• 

  Download Free sample to learn more about this report.

GLOBAL CRISES BIOINFORMATICS SERVICES MARKET - COVID-19 IMPACT

"Market Growth Obstructed by Pandemic due to Lockdown"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

This has affected the overall supply and demand chains of the particular market. As a result of the government's lockdown and other steps to stop the coronavirus from spreading, all supply activities were postponed, which decreased the amount of product related to consumer goods. The pandemic affected the market. There was a great impact on the market. The market growth was affected the pandemic. The global bioinformatics services market grew positively during the COVID-19 pandemic because of the increased demand for the analysis and interpretation of the virus's genomic data, which made it easier to identify effective vaccines against the infection. Therefore, a small influence from COVID-19 is anticipated on the Bioinformatics Services Market share.

LATEST TREND

"Drug Development to Drive Market Growth"

A latest trend has been witnessed to proliferate the market growth. This particular trend has been recorded to be the most profiting trends that have been upgraded to augment the overall market growth. A key component of gene sequencing diagnostics, bioinformatics has proven a vital tool for examining the genetic origins of disease. Bioinformatics services are also being used more often in tailored vaccination, drug development, therapy, diagnosis, and intervention. The growth for this market has increased because of this trend. This specific trend has influenced the market growth so much so that the revenue and share numbers of this particular product is touching the skies and soaring over.

• 

  Download Free sample to learn more about this report.

BIOINFORMATICS SERVICES MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Sequencing Services, Data Analysis, Drug Discovery Services and Differential.

• Sequencing Services: In the field of bioinformatics, sequencing services are laboratory services that identify the precise nucleotide order of a DNA or RNA molecule.

• Data Analysis: The process of interpreting sizable biological datasets through the use of computer tools and methodologies is known as data analysis in bioinformatics services.

• Drug Discovery Services: In the context of bioinformatics services, drug discovery services refers to the application of bioinformatics methods and tools to help find and create novel medications.

• Differential: Differential analysis in bioinformatics services is the comparison of gene expression levels across conditions or sample groupings.

By Application

Based on application, the global market can be categorized into Genomics, Chemoinformatics and Drug Design, Proteomics, Transcriptomics and Metabolomics.

• Genomics: The use of computational tools and methods to evaluate and interpret massive datasets produced by genome sequencing is referred to as bioinformatics services in genomics.

• Chemoinformatics and Drug Design: In Chemoinformatics and Drug Design, bioinformatics services relate to the use of computational biology tools and methods.

• Proteomics: Bioinformatics services in proteomics are the use of algorithms and computer tools to the analysis and interpretation of huge datasets produced by proteomics investigations.

• Transcriptomics: In transcriptomics, bioinformatics services are the use of computer tools and algorithms to examine big datasets produced by transcriptome research.

• Metabolomics: In metabolomics, bioinformatics services are the use of computational tools and algorithms for the analysis and interpretation of huge datasets produced by metabolomics investigations.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

DRIVING FACTORS

"Developments to Boost the Market"

This is the major factor attributing the growth of this particular market. This factor is majorly involved in taking the revenue numbers above the skies and soaring greater heights and also the sales and demands have been proliferation and increased its value to greater extent. The constant increase of bioinformatics applications across a range of industries is one of the key factors propelling the worldwide bioinformatics services market. These applications include gene expression, drug discovery, protein structure and function prediction, genome sequencing and analysis, and gene and function identification. As the costs of maintenance and security rise with the use of any bioinformatics software or instrument, other aspects like development and processing expenses also rise. Researchers and industry participants are encouraged to contract these services in order to lower the cost of purchasing these tools or platforms. There is a surge of interest for bioinformatics services due to the rise of new companies providing these services. This particular factor has been proved to a boon for this particular product market. These factors are anticipated to drive the market growth during the forecast period.

"Patient Care to Expand the Market"

This is the second major factor attributing the growth of this particular  market and has resulted in the hike of revenue numbers so much so that they are touching the skies. Clients benefit from it. This particular product market has touched new levels of lucrative revenue numbers and has also recorded to be the boon for this particular product market growth. In addition to changing patient care, this approach has a big influence on medication development procedures since pharmaceutical corporations want to develop more potent and specialized treatments. Enhancing patient outcomes and promoting customized treatment depend heavily on the strategic alliances and partnerships that biotech companies and bioinformatics software suppliers have. These factors are anticipated to drive the market growth in the present times and also during the forecast period.

RESTRAINING FACTOR

"Complications to Impede Market Growth"

These particular solutions have been very helpful yet extremely costly as well. This particular restraining factor has caused the revenue numbers to impede with extremely low yields and declining the sales and demand for this market. Lack of standards in the integration and management of varied biological data is one of the main issues facing the market. Large and complicated data sets, including gene expression and genome sequences, are difficult to handle and interpret. Furthermore, skilled specialists are needed to design accurate and efficient algorithms that match with these standards, and emerging nations lack these professionals. When working with enormous data sets, resolving scalability and ethical issues is therefore a significant constraint that is anticipated to limit the growth of the bioinformatics services market. This particular factor is anticipated to restrain the market growth and drastically reduce the sales and demands of this particular product market.

OPPORTUNITY

"Past-Time Activities To Create Opportunity for the Product in the Market"

This particular opportunity has been attributing the market growth immensely. Increased use multi-omics approaches to study complex biological systems, the need for software programs that can handle diverse data sets and provide integrated insights is expected to increase. This opportunity is very useful. The growth of the market can be done by this opportunity. Businesses that can create user-friendly, scalable, and broad bioinformatics platforms will be well-positioned to take advantage of this trend and propel market expansion.

CHALLENGE

"Lack of Technology Could Be a Potential Challenge for Consumers"

There are several limitations that will prevent the market from expanding. There are many potential in the bioinformatics software business, but there are also a number of risks and difficulties. Because biological data is sensitive, one of the main obstacles is the requirement for strong data security and privacy protections. Furthermore, the industry's quick technical development could make it more competitive and put pressure on businesses to constantly innovate, which could endanger the stability of the market. This particular factor has been drastically challenging for the market growth and has become another major restraining factor.

• 

  Download Free sampleto learn more about this report.

BIOINFORMATICS SERVICES MARKET REGIONAL INSIGHTS

NORTH AMERICA

For the foreseeable future, North America is expected to account for the greatest portion of the global At the moment, the bioinformatics software market is dominated by North America. The region's high level of technological infrastructure, substantial investment in healthcare R&D, and the presence of several important market participants are all factors contributing to its dominance.The region's emphasis on precision medicine efforts and the use of bioinformatics in clinical settings is propelling the market's expansion. The United States Bioinformatics Services Market has anticipated to augment immensely over the forecast period. Almost all of the worldwide revenue share came from North America.

EUROPE

The European market for this particular market has been accounted for attributing the over all global shares for this particular product service market. The European Bioinformatics Services market is currently worth a substantial amount of the global market. This region is growing because of the factors. This region has grown because of increased demand. With significant financing for genomic research and a focus on personalized medicine, Europe is another important location in the bioinformatics software market. Countries are leading the way in bioinformatics research thanks to government programs and partnerships with universities. The region's emphasis on environmentally friendly healthcare options and the incorporation of bioinformatics into medication development procedures are anticipated to propel market expansion.

ASIA

Over the course of the projection period, Asia Pacific is anticipated to experience the quickest growth in the global Bioinformatics Services market. This region has seen a great amount of growth for this market. The growth for this region is expanding because of various benefits and factors. This region is growing. The product has increased growth in this region. The Asia Pacific region is anticipated to show the largest growth throughout the forecast period and the growing use of bioinformatics in developing. The region's expanding market is being aided by the increased emphasis on precision medicine and the use of bioinformatics in clinical diagnostics.

KEY INDUSTRY PLAYERS

"Leading Players adopt Acquisition Strategies to Stay Competitive"

Several players in the market are using acquisition strategies to build their business portfolio and strengthen their market position. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the market.

LIST OF TOP COMPANIES

• Illumina (U.S.)
• Thermo Fisher Scientific (U.S.)
• Eurofins Scientific (U.S.)
• BGI (China)
• NeoGenomics (U.S.)

KEY INDUSTRY DEVELOPMENT

August 2024: In order to expedite the development of a high-throughput, next-generation short-read sequencer, PacBio consented to purchase Apton Biosystems, Inc.

Five Recent Developments (2023-2025)

• June 2023: Psomagen introduced the PacBio Revio sequencing platform, expanding high-throughput whole-genome, RNA sequencing, and microbiome bioinformatics services.
• August 2023: PacBio signed an agreement to acquire Apton Biosystems, strengthening next-generation short-read sequencing capabilities for advanced bioinformatics workflows.
• March 2023: Emmes acquired Essex Management, adding bioinformatics and health information technology expertise for government and clinical research programs.
• August 2024: Illumina partnered with the Broad Institute to develop CRISPR-based sequencing kits and expand large-scale genomic analysis capabilities.
• April 2025: Signios Biosciences launched an AI-powered multiomics bioinformatics platform integrating genomics, proteomics, and transcriptomics for precision medicine research.

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.market affecting the forecasting period. With detailed studies done, it also offers a comprehensive.